^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | pegylated liposomal doxorubicin (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Caelyx pegylated liposomal is indicated:...as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk…
